Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Drugmakers continue 'off-label marketing' despite large fines
Drugmakers continue 'off-label marketing' despite large fines
Drugmakers continue 'off-label marketing' despite large fines
Submitted by
admin
on June 7, 2010 - 10:24pm
Source:
Star Ledger, NJ
News Tags:
off-label
Topamax
AstraZeneca
Pfizer
JNJ
Headline:
Drugmakers continue 'off-label marketing' despite large fines
Do Not Allow Advertisers to Use My Personal information
